153 related articles for article (PubMed ID: 15299077)
1. Polyomavirus middle T-induced mammary intraepithelial neoplasia outgrowths: single origin, divergent evolution, and multiple outcomes.
Maglione JE; McGoldrick ET; Young LJ; Namba R; Gregg JP; Liu L; Moghanaki D; Ellies LG; Borowsky AD; Cardiff RD; MacLeod CL
Mol Cancer Ther; 2004 Aug; 3(8):941-53. PubMed ID: 15299077
[TBL] [Abstract][Full Text] [Related]
2. Inducible and coupled expression of the polyomavirus middle T antigen and Cre recombinase in transgenic mice: an in vivo model for synthetic viability in mammary tumour progression.
Rao T; Ranger JJ; Smith HW; Lam SH; Chodosh L; Muller WJ
Breast Cancer Res; 2014 Jan; 16(1):R11. PubMed ID: 24457046
[TBL] [Abstract][Full Text] [Related]
3. Transgenic Polyoma middle-T mice model premalignant mammary disease.
Maglione JE; Moghanaki D; Young LJ; Manner CK; Ellies LG; Joseph SO; Nicholson B; Cardiff RD; MacLeod CL
Cancer Res; 2001 Nov; 61(22):8298-305. PubMed ID: 11719463
[TBL] [Abstract][Full Text] [Related]
4. Mammary tumor latency is increased in mice lacking the inducible nitric oxide synthase.
Ellies LG; Fishman M; Hardison J; Kleeman J; Maglione JE; Manner CK; Cardiff RD; MacLeod CL
Int J Cancer; 2003 Aug; 106(1):1-7. PubMed ID: 12794750
[TBL] [Abstract][Full Text] [Related]
5. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
Zhang H; Stephens LC; Kumar R
Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771
[TBL] [Abstract][Full Text] [Related]
6. Rapamycin inhibits growth of premalignant and malignant mammary lesions in a mouse model of ductal carcinoma in situ.
Namba R; Young LJ; Abbey CK; Kim L; Damonte P; Borowsky AD; Qi J; Tepper CG; MacLeod CL; Cardiff RD; Gregg JP
Clin Cancer Res; 2006 Apr; 12(8):2613-21. PubMed ID: 16638874
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneity of mammary lesions represent molecular differences.
Namba R; Maglione JE; Davis RR; Baron CA; Liu S; Carmack CE; Young LJ; Borowsky AD; Cardiff RD; Gregg JP
BMC Cancer; 2006 Dec; 6():275. PubMed ID: 17147824
[TBL] [Abstract][Full Text] [Related]
8. PyV-mT-induced parotid gland hyperplasia as detected by altered lectin reactivity is not modulated by inducible nitric oxide deficiency.
Ellies LG
Arch Oral Biol; 2003 Jun; 48(6):415-22. PubMed ID: 12749913
[TBL] [Abstract][Full Text] [Related]
9. Epithelial-mesenchymal plasticity is a decisive feature for the metastatic outgrowth of disseminated WAP-T mouse mammary carcinoma cells.
Maenz C; Lenfert E; Pantel K; Schumacher U; Deppert W; Wegwitz F
BMC Cancer; 2015 Mar; 15():178. PubMed ID: 25886487
[TBL] [Abstract][Full Text] [Related]
10. Molecular characterization of the transition to malignancy in a genetically engineered mouse-based model of ductal carcinoma in situ.
Namba R; Maglione JE; Young LJ; Borowsky AD; Cardiff RD; MacLeod CL; Gregg JP
Mol Cancer Res; 2004 Aug; 2(8):453-63. PubMed ID: 15328372
[TBL] [Abstract][Full Text] [Related]
11. Mammary carcinoma behavior is programmed in the precancer stem cell.
Damonte P; Hodgson JG; Chen JQ; Young LJ; Cardiff RD; Borowsky AD
Breast Cancer Res; 2008; 10(3):R50. PubMed ID: 18522749
[TBL] [Abstract][Full Text] [Related]
12. Biological and genetic properties of the p53 null preneoplastic mammary epithelium.
Medina D; Kittrell FS; Shepard A; Stephens LC; Jiang C; Lu J; Allred DC; McCarthy M; Ullrich RL
FASEB J; 2002 Jun; 16(8):881-3. PubMed ID: 11967232
[TBL] [Abstract][Full Text] [Related]
13. Contributions of the RhoA guanine nucleotide exchange factor Net1 to polyoma middle T antigen-mediated mammary gland tumorigenesis and metastasis.
Zuo Y; Ulu A; Chang JT; Frost JA
Breast Cancer Res; 2018 May; 20(1):41. PubMed ID: 29769144
[TBL] [Abstract][Full Text] [Related]
14. Activation of the c-Src tyrosine kinase is required for the induction of mammary tumors in transgenic mice.
Guy CT; Muthuswamy SK; Cardiff RD; Soriano P; Muller WJ
Genes Dev; 1994 Jan; 8(1):23-32. PubMed ID: 7507074
[TBL] [Abstract][Full Text] [Related]
15. Muc1 affects c-Src signaling in PyV MT-induced mammary tumorigenesis.
Al Masri A; Gendler SJ
Oncogene; 2005 Sep; 24(38):5799-808. PubMed ID: 15897873
[TBL] [Abstract][Full Text] [Related]
16. Signal transduction in transgenic mouse models of human breast cancer--implications for human breast cancer.
Marcotte R; Muller WJ
J Mammary Gland Biol Neoplasia; 2008 Sep; 13(3):323-35. PubMed ID: 18651209
[TBL] [Abstract][Full Text] [Related]
17. Haploid inactivation of the amplified-in-breast cancer 3 coactivator reduces the inhibitory effect of peroxisome proliferator-activated receptor gamma and retinoid X receptor on cell proliferation and accelerates polyoma middle-T antigen-induced mammary tumorigenesis in mice.
Zhang H; Kuang SQ; Liao L; Zhou S; Xu J
Cancer Res; 2004 Oct; 64(19):7169-77. PubMed ID: 15466215
[TBL] [Abstract][Full Text] [Related]
18. Functional analysis of mouse keratin 8 in polyoma middle T-induced mammary gland tumours.
Baribault H; Wilson-Heiner M; Muller W; Penner J; Bakhiet N
Transgenic Res; 1997 Nov; 6(6):359-67. PubMed ID: 9423286
[TBL] [Abstract][Full Text] [Related]
19. The induction of uterine leiomyomas and mammary tumors in transgenic mice expressing polyomavirus (PyV) large T (LT) antigen is associated with the ability of PyV LT antigen to form specific complexes with retinoblastoma and CUTL1 family members.
Webster MA; Martin-Soudant N; Nepveu A; Cardiff RD; Muller WJ
Oncogene; 1998 Apr; 16(15):1963-72. PubMed ID: 9591780
[TBL] [Abstract][Full Text] [Related]
20. Transformation of enriched mammary cell populations with polyomavirus middle T antigen influences tumor subtype and metastatic potential.
Drobysheva D; Smith BA; McDowell M; Guillen KP; Ekiz HA; Welm BE
Breast Cancer Res; 2015 Oct; 17(1):132. PubMed ID: 26429062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
